[Thrombolytic therapy for pulmonary thromboembolism]

Klin Med (Mosk). 2004;82(10):4-8.
[Article in Russian]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Blood Coagulation Tests
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use
  • Heparin / administration & dosage
  • Heparin / therapeutic use
  • Humans
  • Multicenter Studies as Topic
  • Plasminogen Activators / administration & dosage
  • Plasminogen Activators / therapeutic use
  • Prospective Studies
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / drug therapy*
  • Pulmonary Embolism / mortality
  • Pulmonary Embolism / surgery
  • Randomized Controlled Trials as Topic
  • Registries
  • Risk Factors
  • Streptokinase / administration & dosage
  • Streptokinase / therapeutic use
  • Thrombolytic Therapy*
  • Time Factors
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use
  • Tomography, Spiral Computed
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Urokinase-Type Plasminogen Activator / therapeutic use
  • Vena Cava Filters

Substances

  • Fibrinolytic Agents
  • Heparin
  • Streptokinase
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator